SERD-NHC-Au(I) complexes for dual targeting ER and TrxR to induce ICD in breast cancer

• Үндсэн зохиолчид: Yunlong Lu (Зохиогч), Xinyu Sheng (Зохиогч), Chao Liu (Зохиогч), Zhenlin Liang (Зохиогч), Xin Wang (Зохиогч), Lijuan Liu (Зохиогч), Zhenfan Wen (Зохиогч), Zhibin Yang (Зохиогч), Qianming Du (Зохиогч), Wukun Liu (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Elsevier, 2023-04-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

The development of selective estrogen receptor degraders (SERDs) has brought new ideas for the clinical treatment of ER-positive advanced breast cancer. The successful application of combinational therapy inspired the exploration of other targets to prevent breast cancer progression. Thioredoxin red...